logo

Merit Cudkowicz, MD

Merit Cudkowicz, MD, MSc

Neurology Boston, MA

Julieanne Dorn Professor of Neurology, Massachusetts General Hospital

Office Address

Office Map
  • 15 Parkman St
    Wac 836
    Boston, MA 02114
    Phone: (617) 724-1873
    Fax: (617) 724-7290

Dr. Cudkowicz's Clinical Specialties & Interests

  • Neurology: Neuromuscular Medicine, Neurodegenerative

Dr. Cudkowicz's Education & Medical Training

  • Massachusetts General HospitalMassachusetts General HospitalResidency, Neurology
  • Beth Israel Deaconess Medical CenterBeth Israel Deaconess Medical CenterResidency, Internal Medicine
  • Harvard Med SchHarvard Medical SchoolMedical School

Dr. Cudkowicz's Certifications & Licensure

  • MA State Medical LicenseMA State Medical License1994 - 2015
  • American Board of Psychiatry and NeurologyAmerican Board of Psychiatry and NeurologyNeurology

Dr. Cudkowicz's Clinical Trials

Dr. Cudkowicz's Publications & Presentations

PubMed | Citations by Web of Science®

Lectures

  • 65th AAN Annual MeetingAmerican Academy of Neurology (AAN), San Diego, California - 3/16/2013

Other

Grant Support

  • Clinical Coordinating Center Network Of Excellence In Neuroscience Clinical Trial
    Clinical Coordinating Center Network Of Excellence In Neuroscience Clinical TrialNational Institute Of Neurological Disorders And Stroke
    2011 - 2011
  • Phase II/III Study Of Arimoclomol In The Treatment Of SOD1 Positive Familial?.
    Phase II/III Study Of Arimoclomol In The Treatment Of SOD1 Positive Familial?.Food And Drug Administration
    2011 - 2011
  • Clinical Trial Of Ceftriaxone In Subjects With ALS
    Clinical Trial Of Ceftriaxone In Subjects With ALSNational Institute Of Neurological Disorders And Stroke
    2010 - 2011
  • Multi-Center Validation Of Biomarkers For Motor Neuron Disease
    Multi-Center Validation Of Biomarkers For Motor Neuron DiseaseNational Institute Of Neurological Disorders And Stroke
    2010 - 2010
  • Generation And Characterization Of Amyotrophic Lateral Sclerosis IPS Cells
    Generation And Characterization Of Amyotrophic Lateral Sclerosis IPS CellsNational Institute Of Neurological Disorders And Stroke
    2009 - 2010
  • Multi-Center Validation Of Biomarkers For Motor Neuron Disease
    Multi-Center Validation Of Biomarkers For Motor Neuron DiseaseNational Institute Of Neurological Disorders And Stroke
    2009 - 2010
  • Clinical Trial: Open-Label Arimoclomol Extension Protocol
    Clinical Trial: Open-Label Arimoclomol Extension ProtocolNational Center For Research Resources
    2008 - 2008
  • Coenzyme Q10 In Huntington'S Disease
    Coenzyme Q10 In Huntington'S DiseaseNational Institute Of Neurological Disorders And Stroke
    2008 - 2010
  • Phase II/III Study Of Arimoclomol In The Treatment Of SOD1 Positive Familial?.
    Phase II/III Study Of Arimoclomol In The Treatment Of SOD1 Positive Familial?.Food And Drug Administration
    2008 - 2008
  • Open-Label Arimoclomol Extension Protocol
    Open-Label Arimoclomol Extension ProtocolNational Center For Research Resources
    2007 - 2007
  • Identification Of Diagnostic Biomarkers And Therapeutic Agents For ALS
    Identification Of Diagnostic Biomarkers And Therapeutic Agents For ALSNational Center For Research Resources
    2007 - 2007
  • Safety Study Of Aeol10150 In Patients With Amyotrophic Lateral Sclerosis
    Safety Study Of Aeol10150 In Patients With Amyotrophic Lateral SclerosisNational Center For Research Resources
    2006 - 2006
  • Safety And Pharmacokinetics Study Of Arimoclomol In ALS
    Safety And Pharmacokinetics Study Of Arimoclomol In ALSNational Center For Research Resources
    2006 - 2007
  • Clinical Trial Of Ceftriaxone In ALS
    Clinical Trial Of Ceftriaxone In ALSNational Institute Of Neurological Disorders And Stroke
    2006 - 2009
  • Safety And Dose Escalating Study Of Napb In ALS
    Safety And Dose Escalating Study Of Napb In ALSNational Center For Research Resources
    2006 - 2006
  • Multi-Dose Placebo-Controlled Phase I Study Of AEOL 10150 In Patients With ALS
    Multi-Dose Placebo-Controlled Phase I Study Of AEOL 10150 In Patients With ALSNational Center For Research Resources
    2006 - 2007
  • A Clinical Trial Of Coenzyme Q10 In Patients With Amyotrophic Lateral Sclerosis
    A Clinical Trial Of Coenzyme Q10 In Patients With Amyotrophic Lateral SclerosisNational Center For Research Resources
    2005 - 2005
  • Determ Of Biological Mrkrs In Cerebrospinal Fld Subj W/Amyotrophic Ltral Sclero
    Determ Of Biological Mrkrs In Cerebrospinal Fld Subj W/Amyotrophic Ltral ScleroNational Center For Research Resources
    2005 - 2005
  • Double Blind Study Of Minocycline In HD
    Double Blind Study Of Minocycline In HDFood And Drug Administration
    2005 - 2007
  • Coenzyme Q10 In Huntington'S Disease
    Coenzyme Q10 In Huntington'S DiseaseNational Institute Of Neurological Disorders And Stroke
    2005 - 2007
  • Pilot Safety And Tolerability Study Of COQ10 In HD And In Normal
    Pilot Safety And Tolerability Study Of COQ10 In HD And In NormalNational Center For Research Resources
    2004 - 2005
  • Clinical Trial Of Celebrex In Subjects With Amyotrophic Lateral Sclerosis (ALS)
    Clinical Trial Of Celebrex In Subjects With Amyotrophic Lateral Sclerosis (ALS)National Center For Research Resources
    2004 - 2005
  • Histamine Dihydrochloride In ALS
    Histamine Dihydrochloride In ALSNational Center For Research Resources
    2004 - 2005
  • Clinical Trial Of Ceftriaxone In ALS
    Clinical Trial Of Ceftriaxone In ALSNational Institute Of Neurological Disorders And Stroke
    2004 - 2004
  • Metabolomic Signatures In ALS
    Metabolomic Signatures In ALSNational Institute Of Environmental Health Sciences
    2004 - 2005
  • Clinical Trial Of Coenzyme Q10 In Patients With ALS
    Clinical Trial Of Coenzyme Q10 In Patients With ALSNational Center For Research Resources
    2004 - 2004
  • Clinical Trial Of Topiramate In ALS
    Clinical Trial Of Topiramate In ALSNational Institute Of Neurological Disorders And Stroke
    2000 - 2003
  • Topiramate Clinical Trial In Amyotrophic Lateral Scleros
    Topiramate Clinical Trial In Amyotrophic Lateral SclerosNational Center For Research Resources
    2000 - 2002
  • Rmethubdnf Intrathecal Infusion In ALS
    Rmethubdnf Intrathecal Infusion In ALSNational Center For Research Resources
    2000 - 2002
  • Coenzyme Q10 And Remacemide--Evaluation In Huntington'S Disease
    Coenzyme Q10 And Remacemide--Evaluation In Huntington'S DiseaseNational Center For Research Resources
    1998 - 2002
  • Biological Markers In CSF In Subjects With Amyotrophic Lateral Sclerosis
    Biological Markers In CSF In Subjects With Amyotrophic Lateral SclerosisNational Center For Research Resources
    1998 - 1999
  • Risk Factors And Therapeutic Strategies In ALS
    Risk Factors And Therapeutic Strategies In ALSNational Institute Of Neurological Disorders And Stroke
    1996 - 2000

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Massachusetts Blue Care Elect PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • First Health PPO
  • Great West PPO
  • Harvard Pilgrim HMO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Tufts Health Plan PPO
  • UniCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Physicians, view Dr. Cudkowicz's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV